Evidence map›Paper›PMID 41839937›Full record

ArticleScientific reports2026

ProSeg: multi-scale context fusion for high-precision prostate segmentation in MRI.

Jiangwei Qin, Yanli Yang

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jiangwei QinGuangdong Pharmaceutical University, Guangzhou, China. qinjw@gdpu.edu.cn.
Yanli YangDepartment of Pain Medicine, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Third Hospital of Shanxi Medical University, Tongji Shanxi Hospital, Shanxi, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prostate MRI segmentation is critical for accurate diagnosis and treatment planning but remains challenging due to the complex interplay between the peripheral zone's thin, irregular boundaries and the central gland's homogeneous textures, compounded by variability across imaging protocols. To address these challenges, we propose ProSeg, a novel deep learning framework featuring a specialized ProSeg block that integrates dual complementary processes: (1) anisotropic convolutions for precise peripheral zone boundary delineation and (2) cross-slice attention mechanisms for robust central gland texture modeling. Extensive evaluations on the Promise12 and Promise158 datasets demonstrate ProSeg's state-of-the-art performance, achieving Dice scores of 84.31% (peripheral zone) and 57.92% (central gland) on Promise12, and 83.15% (peripheral zone) and 56.38% (central gland) on Promise158, significantly outperforming existing methods. ProSeg's consistent accuracy across diverse protocols highlights its clinical potential for reliable prostate zonal segmentation in real-world settings.

Indexed as

Image Interpretation, Computer-AssistedImage Processing, Computer-AssistedMagnetic Resonance ImagingProstateProstatic NeoplasmsAlgorithmsDeep LearningHumansMaleCentral glandMedical image analysisPeripheral zoneProstate segmentation

Identifiers

PMID41839937
PMCPMC13121527

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.